dc.creator | Lenz, Rony | |
dc.creator | Zárate, Aldo | |
dc.creator | Rodríguez, Jorge | |
dc.creator | Ramírez, Jorge | |
dc.date.accessioned | 2019-03-15T16:07:43Z | |
dc.date.available | 2019-03-15T16:07:43Z | |
dc.date.created | 2019-03-15T16:07:43Z | |
dc.date.issued | 2014 | |
dc.identifier | Revista Medica de Chile, Volumen 142, Issue 7, 2018, Pages 841-849 | |
dc.identifier | 07176163 | |
dc.identifier | 00349887 | |
dc.identifier | 10.4067/S0034-98872014000700004 | |
dc.identifier | https://repositorio.uchile.cl/handle/2250/166273 | |
dc.description.abstract | © 2014, Sociedad Medica de Santiago. All rights reserved.Background: Complications increase treatment costs of diabetes mellitus (DM). An adequate metabolic control of the disease could reduce these costs. Aim: To evaluate the costs of medical care for a cohort of patients with DM, according to their degree of metabolic compensation. Material and Methods: All diabetic patients attended in a regional hospital from 2005 to 2010 were analyzed. A correlational study between costs of individual healthcare and levels of glycosylated hemoglobin (HbA1c), was performed in a series of annual cross-sectional measurements. Results: The study comprised 1,644 diabetic patients. During the study period the average cost of healthcare per patient increased from $878,000 to more than $1,000,000 Chilean pesos (CLP) during the study period. The percentage of patients with HbA1c levels below 7.0% varied between 43.0% and 54.9%. Costs for patients with HbA1c levels between 7 and 8.9% were 1.3 to 1.5 times g | |
dc.language | en | |
dc.publisher | Sociedad Medica de Santiago | |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Chile | |
dc.source | Revista Medica de Chile | |
dc.subject | Diabetes mellitus | |
dc.subject | Glycosylated | |
dc.subject | Health care costs | |
dc.subject | Hemoglobin A | |
dc.title | Levels of glycosylated hemoglobin and the difference in the cost of health care for diabetic patients: An econometric study Niveles de hemoglobina glicosilada y diferencia en el gasto en salud de pacientes diabéticos: Un estudio econométrico | |
dc.type | Artículos de revistas | |